Lithium Controlled-Release and Extended-Release Tablets and Tri Biozene
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Tri Biozene and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: bacitracin / neomycin / polymyxin b / pramoxine topical
Brand name: Neosporin + Pain Relief Ointment, Tri Biozene
Synonyms: Bacitracin, Neomycin, Polymyxin B, and Pramoxine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Tri Femynor
- Lithium Controlled-Release and Extended-Release Tablets-Tri Vites with Fluoride and Iron
- Lithium Controlled-Release and Extended-Release Tablets-Tri-Estarylla
- Lithium Controlled-Release and Extended-Release Tablets-Tri-Legest
- Lithium Controlled-Release and Extended-Release Tablets-Tri-Legest Fe
- Lithium Controlled-Release and Extended-Release Tablets-Tri-Linyah
- Tri Biozene-Lithium ER
- Tri Biozene-Lithium Oral Solution
- Tri Biozene-Lithium Salts
- Tri Biozene-Lithium Syrup and Oral Solution
- Tri Biozene-Lithobid
- Tri Biozene-Lithostat